SCHEMBL6997562

SCHEMBL6997562

Cc1ccc2ccccc2c1N1CCNCC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.56
HTR6 P50406 4/20 0.56
NCF1 P14598 3/20 0.56
HTR3E A5X5Y0 3/20 0.56
HTR3B O95264 3/20 0.56
HTR3A P46098 3/20 0.56
HTR3D Q70Z44 3/20 0.56
HTR3C Q8WXA8 3/20 0.56
HTR5A P47898 3/20 0.56
HTR7 P34969 3/20 0.56
TSHR P16473 3/20 0.56
SIGMAR1 Q99720 2/20 0.56
HTR1A P08908 2/20 0.56
HSD17B10 Q99714 2/20 0.56
CYP2D6 P10635 2/20 0.56
NFKB1 P19838 1/20 0.56
HTR1D P28221 1/20 0.56
HTR1B P28222 1/20 0.56
HTR2A P28223 1/20 0.56
MTOR P42345 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6001737 0.81 HRH4 (0.51) CYP1A2HTR3EHTR3BHTR3AHTR3D
SCHEMBL5366514 0.80 HTR6 (0.56) CYP1A2HTR6NCF1HTR3EHTR3B
SCHEMBL7000976 0.80 HTR3E (0.54) CYP1A2HTR6NCF1HTR3EHTR3B
SCHEMBL19972406 0.79 HCAR1 (0.43) CYP1A2TSHRALDH1A1LMNACYP2A6
SCHEMBL5368737 0.77 HTR6 (0.49) CYP1A2HTR6NCF1HTR3EHTR3B
SCHEMBL19297202 0.77 HTR6 (0.49) CYP1A2HTR6NCF1HTR3EHTR3B
SCHEMBL336283 0.76 ADRB1 (0.63) CYP1A2HTR3EHTR3BHTR3AHTR3D
SCHEMBL27802505 0.75 HCRTR1 (0.38) CYP1A2HTR6NCF1HTR3EHTR3B
Hydrochloric Acid SCHEMBL6739727 0.74 ADRB1 (0.61) CYP1A2HTR3EHTR3BHTR3AHTR3D
SCHEMBL6601670 0.74 MAPT (0.51) CYP1A2HTR6NCF1HTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1023296-B1 3-SUBSTITUTED PYRIDO 3',4':4,5] THIENO 2,3-D] PYRIMIDINE DERIVATIVES, AND PRODUCTION AND USE OF THE SAME ABBOTT GMBH & CO KG (DE) 2003-12-17 EP disclosed
EP-0927184-B1 3-SUBSTITUTED PYRIDO 4',3':4,5]THIENO 2,3-D]PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE ABBOTT GMBH & CO KG (DE) 2003-10-22 EP disclosed
US-6387912-B1 STROKE THERAPY BASF AKTIENGESELLSCHAFT (DE) 2002-05-14 US disclosed
US-6355647-B1 INHIBIT THE SEROTONIN REUPTAKE. HYPERPROLACTINEMIA, VASOSPASMS, HYPERTENSION, GASTROINTESTINAL DISORDERS ASSOCIATED WITH MOTILITY AND SECRETION ABBOTT LABORATORIES 2002-03-12 US disclosed
EP-1140096-A1 UTILIZATION OF PYRIMIDINE DERIVATIVES FOR PREVENTING AND TREATING CEREBRAL ISCHAEMIA BASF AKTIENGESELLSCHAFT (DE) 2001-10-10 EP disclosed
US-6222034-B1 AS SEROTININ RECEPTOR ANTAGONISTS; FOR THERAPY OF DEPRESSION, CENTRAL NERVOUS SYSTEM DISORDERS BASF AKTIENGESELLSCHAFT (DE) 2001-04-24 US disclosed
US-6159981-A 3-substituted pyrido [3',4':4,5] Thieno [2,3-d] pyrimidine derivatives, and production and use of the same BASF AKTIENGESELLSCHAFT (DE) 2000-12-12 US disclosed
US-6159962-A 3-substituted 3,4-dihydro-thieno[2,3-D]pyrimidine derivatives and production and use of the same BASF AKTIENGESELLSCHAFT (DE) 2000-12-12 US disclosed
WO-2000041695-A1 UTILIZATION OF PYRIMIDINE DERIVATIVES FOR PREVENTING AND TREATING CEREBRAL ISCHAEMIA BASF AKTIENGESELLSCHAFT (DE) 2000-07-20 WO disclosed
EP-0927184-A1 3-SUBSTITUTED PYRIDO 4',3':4,5]THIENO 2,3-D]PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 1999-07-07 EP disclosed
WO-1998011110-A1 3-SUBSTITUTED PYRIDO[4',3':4,5]THIENO[2,3-D]PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 1998-03-19 WO disclosed